Non-response to first-line anti-tuberculosis treatment in Sikkim, India: a risk-factor analysis study
This article aims to assess the factors associated with non-response to treatment
Abstract
Sikkim, India, has the highest proportion of tuberculosis (TB) patients on first-line anti-tuberculosis regimens with the outcome 鈥榝ailure鈥� or 鈥榮hifted to regimen for multidrug-resistant TB (MDR-TB)鈥�. This article aims to assess the factors associated with non-response to treatment, i.e., 鈥榝ailure鈥� or 鈥榮hifted to MDR-TB regimen鈥�.
This research was supported by the UK Department for International Development鈥檚 Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)
Citation
Singhi L, Sagili KD, Sharath BN, Bhandari K, Dadul PK, Gautam M, Ravichandra C, Chadha S, Satyanarayana S. Non-response to first-line anti-tuberculosis treatment in Sikkim, India: a risk-factor analysis study. Public Health Action. 2018 Dec 21;8(4):162鈥�8.